Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
Each year more than 4,000 choose NUI Galway as their University of choice. Find out what life at NUI Galway is all about here.
About NUI Galway
About NUI Galway
Since 1845, NUI Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
Colleges & Schools
Colleges & Schools
NUI Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a rang of key areas of expertise.
- Research Office
Business & Industry
Guiding Breakthrough Research at NUI Galway
We explore and facilitate commercial opportunities for the research community at NUI Galway, as well as facilitating industry partnership.
- Alumni, Friends & Supporters
At NUI Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Surgeon Calls for Public Awareness Campaign to Stem Dramatic Rise in Head and Neck Cancers
Friday, 17 May 2013
Conference organisers: NUI Galway’s Diarmuid Coughlan, and Professor Ivan Keogh, Head of the Academic Department of Otorhinolaryngology at NUI Galway and Consultant Otolaryngologist at Galway University Hospitals; and Tony O’Connor, Consultant Otolaryngologist, Bon Secours Hospital, Galway and Academic Department of Otorhinolaryngology NUI Galway.
New research project will analyse samples dating back to 1994
Lack of public awareness of a new cancer epidemic is causing lasting damage to patients, delegates at symposium on head and neck cancer in NUI Galway heard today.
Professor Ivan Keogh, Head of the Academic Department of Otorhinolaryngology at NUI Galway and Consultant Otolaryngologist at Galway University Hospitals, said that head and neck cancers related to the Human Papilloma Virus (HPV) are rising dramatically and are projected to surpass cervical cancer by 2020.
“There is a changing nature in the cause of head and neck cancers from traditional heavy smoking and drinking use to HPV. While the survival rate for the latter if very good, these cancers are very disfiguring. Often, treated patients have swallowing and speech problems. We need an awareness campaign so that individuals, as well as their GPs and dentists to become aware of the early symptoms”, said surgeon Professor Keogh, who has seen first-hand the numbers of cases rise dramatically in his clinic.
At the symposium, Dr Linda Sharp, PhD, Senior Epidemiologist with the National Cancer Registry Ireland, announced a new project involving the HRB funded Irish Cervical Screening Research Consortium collaboration, CERVIVA, in partnership with surgeons and pathologists. Commencing in autumn 2013, the project will see a major investigation of HPV in squamous cell carcinomas of the oropharynx, oral cavity and larynx diagnosed since 1994. This will provide the first population-based data on the epidemiology of HPV infection in head and neck cancer in the Republic of Ireland.
In Ireland, head and neck cancers are the 6th most common cancer in men and 16th most common in women. With the incidence of HPV-related head and neck cancer more likely to occur in men than women it raises the debate about vaccinating boys against this sexually-transmitted virus, as is now taking place in Australia.
“Australia and Canada are already rolling out vaccination programmes for boys. Ireland will need to consider it’s position on this over the near future and take a reasoned look at all the factors involved”, said co-organiser, Mr Tony O’Connor, Consultant Otolaryngologist, Bon Secours Hospital, Galway.
The event also heard from internationally-renowned keynote speakers from the Johns Hopkins Medical Institution. Dr Sara Pai and Dr William Westra, shared their experiences of the cancer which has now been deemed an ‘epidemic’ by the American Cancer Society. Dr Brenda Corcoran, HSE National Immunisation Office, concluded the symposium.
The symposium was organised by NUI Galway’s Academic Department of Otorhinolaryngology and School of Economics, the event is funded by the Health Research Board (HRB) as part of its Knowledge Exchange and Dissemination Scheme (KEDS).
Author: Marketing and Communications Office, NUI Galway